Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Combining Data to Find New Indications, Develop New Targets & Predict Adverse Events

Posted on August 21st, 2017 by in Pharma R&D

High-quality compound bioactivity data and information about biological pathways and potential drug targets is more readily available than ever—and in enormous amounts that are often daunting to researchers (more…)